Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PREGABALIN EXTENDED-RELEASE TABLETS. PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
Pregabalin extended-release tablets are indicated for the management of: Neuropathic pain associated with diabetic peripheral neuropathy Postherpetic neuralgia Efficacy of pregabalin extended-release tablets has not been established for the management of fibromyalgia or as adjunctive therapy for adult patients with partial onset seizures.
- generic_name
- pregabalin
- product_names
- PREGABALIN
- ndc
- 69986-013, 69986-014, 69986-015, 69986-013-01, 69986-014-01, 69986-015-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en